In dedifferentiated HCC cells, METTL14 is downregulated, with decreased levels of HNF3γ mRNA halting cancer cell differentiation.[30] METTL3 overexpression is associated with enhanced cellular differentiation in glioblastoma. Here, METTL3 is linked to hepatocellular carcinoma.